- Home
- ARGX vs MLM Comparison
ARGX vs MLM Comparison
Compare ARGX & MLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- MLM
- Stock Information
- Founded
- ARGX 2008
- MLM 1993
- Country
- ARGX Netherlands
- MLM United States
- Employees
- ARGX N/A
- MLM N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- MLM Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- ARGX Health Care
- MLM Industrials
- Exchange
- ARGX Nasdaq
- MLM Nasdaq
- Market Cap
- ARGX 37.3B
- MLM 32.1B
- IPO Year
- ARGX 2017
- MLM 1994
- Fundamental
- Price
- ARGX $623.82
- MLM $533.71
- Analyst Decision
- ARGX Strong Buy
- MLM Strong Buy
- Analyst Count
- ARGX 20
- MLM 15
- Target Price
- ARGX $634.50
- MLM $643.79
- AVG Volume (30 Days)
- ARGX 290.3K
- MLM 459.7K
- Earning Date
- ARGX 10-31-2024
- MLM 02-12-2025
- Dividend Yield
- ARGX N/A
- MLM 0.57%
- EPS Growth
- ARGX N/A
- MLM 86.63
- EPS
- ARGX N/A
- MLM 32.12
- Revenue
- ARGX $1,908,659,000.00
- MLM $6,513,200,000.00
- Revenue This Year
- ARGX $61.99
- MLM N/A
- Revenue Next Year
- ARGX $42.48
- MLM $10.42
- P/E Ratio
- ARGX N/A
- MLM $16.57
- Revenue Growth
- ARGX 85.56
- MLM N/A
- 52 Week Low
- ARGX $349.86
- MLM $479.67
- 52 Week High
- ARGX $644.97
- MLM $633.23
- Technical
- Relative Strength Index (RSI)
- ARGX 58.04
- MLM 29.00
- Support Level
- ARGX $613.95
- MLM $555.04
- Resistance Level
- ARGX $644.97
- MLM $558.48
- Average True Range (ATR)
- ARGX 14.33
- MLM 12.23
- MACD
- ARGX -0.42
- MLM -5.51
- Stochastic Oscillator
- ARGX 50.28
- MLM 13.61
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About MLM Martin Marietta Materials Inc.
Martin Marietta Materials is one of the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). In 2023, Martin Marietta sold 199 million tons of aggregates. Martin Marietta's most important markets include Texas, Colorado, North Carolina, Georgia, and Florida, accounting for most of its sales. The company also produces cement in Texas and uses its aggregates in its asphalt and ready-mixed concrete businesses. Martin's magnesia specialties business produces magnesia-based chemical products and dolomitic lime.